Evidence map›Paper›PMID 36804958›Full record

ArticleImmunity2023

Non-canonical pattern recognition of a pathogen-derived metabolite by a nuclear hormone receptor identifies virulent bacteria in C. elegans.

Nicholas D Peterson, Samantha Y Tse, Qiuyu Judy Huang, Khursheed A Wani, Celia A Schiffer, Read Pukkila-Worley

Open access · greenAbstract read
In one paragraph

Article in Immunity, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. bioRxiv : the preprint server for biology · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  17. Modeling Host-Pathogen Interactions inInternational journal of molecular sciences · 2024
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Nicholas D PetersonProgram in Innate Immunity, Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Samantha Y TseProgram in Innate Immunity, Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Qiuyu Judy HuangDepartment of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Khursheed A WaniProgram in Innate Immunity, Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Celia A SchifferDepartment of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Read Pukkila-WorleyProgram in Innate Immunity, Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA. Electronic address: read.pukkila-worley@umassmed.edu.
University of Massachusetts Chan Medical School · US

Funding

Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Ann E. Rougvie · 2012 to 2026
$7.5M
Medical Scientist Training at UMMS Administrative SupplementT32GM107000 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KIEFE, CATARINA I. · 2013 to 2022
$4.9M
An Immune Surveillance Network in C. elegansR01AI130289 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI PUKKILA-WORLEY, READ · 2017 to 2025
$4.6M
Structurally dissecting APOBEC3's for HIV-1 restriction and beyondR01AI150478 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SCHIFFER, CELIA A. · 2019 to 2024
$3.9M
Sensing bacterial patterns of pathogenesis by an enzymatic TIR proteinR01AI159159 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Read Pukkila-Worley · 2021 to 2026
$3.7M
Innate Immunity Training ProgramT32AI095213 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SILVERMAN, NEAL · 2011 to 2025
$2.5M
Integration of Evolution to Avoid Resistance in Structure Based Drug DesignR01GM135919 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SCHIFFER, CELIA A. · 2020 to 2023
$2.5M
Training in the Molecular Basis of Autoimmunity and AutoinflammationT32AI132152 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Katherine A. Fitzgerald, Ann Marshak-Rothstein · 2018 to 2026
$1.6M
Design of Protease Inhibitors to Target HTLV-1R21AI149716 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SCHIFFER, CELIA A. · 2020 to 2021
$461k
Neuroendocrine regulation of intestinal epithelial immunity in C. elegansR21AI163430 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI PUKKILA-WORLEY, READ · 2021 to 2022
$461k
Detection of intestinal pathogens through host surveillance of bacterial toxinsF30DK127690 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI TSE, SAMANTHA · 2021 to 2025
$171k
Pathogen sensing by nuclear hormone receptors in C. elegans intestinal epithelial cellsF30AI150127 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI PETERSON, NICHOLAS · 2020 to 2023
$132k
NIAID NIH HHS F30 AI150127NIAID NIH HHS R01 AI130289NIAID NIH HHS R01 AI150478NIAID NIH HHS R01 AI159159NIAID NIH HHS R21 AI149716NIAID NIH HHS R21 AI163430NIAID NIH HHS T32 AI095213NIAID NIH HHS T32 AI132152NIDDK NIH HHS F30 DK127690NIGMS NIH HHS R01 GM135919NIGMS NIH HHS T32 GM107000NIH HHS P40 OD010440
6 · The paper itself

Abstract

Distinguishing infectious pathogens from harmless microorganisms is essential for animal health. The mechanisms used to identify infectious microbes are not fully understood, particularly in metazoan hosts that eat bacteria as their food source. Here, we characterized a non-canonical pattern-recognition system in Caenorhabditis elegans (C. elegans) that assesses the relative threat of virulent Pseudomonas aeruginosa (P. aeruginosa) to activate innate immunity. We discovered that the innate immune response in C. elegans was triggered by phenazine-1-carboxamide (PCN), a toxic metabolite produced by pathogenic strains of P. aeruginosa. We identified the nuclear hormone receptor NHR-86/HNF4 as the PCN sensor in C. elegans and validated that PCN bound to the ligand-binding domain of NHR-86/HNF4. Activation of NHR-86/HNF4 by PCN directly engaged a transcriptional program in intestinal epithelial cells that protected against P. aeruginosa. Thus, a bacterial metabolite is a pattern of pathogenesis surveilled by nematodes to identify a pathogen in its bacterial diet.

Indexed as

Caenorhabditis elegansCaenorhabditis elegans ProteinsAnimalsBacteriaGene Expression RegulationImmunity, InnatePseudomonas aeruginosaReceptors, Cytoplasmic and NuclearCaenorhabditis elegans ProteinsReceptors, Cytoplasmic and NuclearCaenorhabditis eleganshost-pathogen interactionsinnate immunityintestinal epithelial cellsnuclear hormone receptorpathogen sensingpattern recognition receptorpatterns of pathogenesisphenazinesPseudomonas aeruginosa

Identifiers

PMID36804958
PMCPMC10101930
OpenAlexW4321208460

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.